The PROgnostic ModEl for chronic lung disease (PRO-MEL): development and temporal validation.
Bronchiectasis
End-of-life
Interstitial lung disease
Lung
Prognostic
Respiratory
Journal
BMC pulmonary medicine
ISSN: 1471-2466
Titre abrégé: BMC Pulm Med
Pays: England
ID NLM: 100968563
Informations de publication
Date de publication:
30 Aug 2024
30 Aug 2024
Historique:
received:
16
01
2024
accepted:
19
08
2024
medline:
31
8
2024
pubmed:
31
8
2024
entrez:
30
8
2024
Statut:
epublish
Résumé
Patients with chronic lung diseases (CLDs), defined as progressive and life-limiting respiratory conditions, experience a heavy symptom burden as the conditions become more advanced, but palliative referral rates are low and late. Prognostic tools can help clinicians identify CLD patients at high risk of deterioration for needs assessments and referral to palliative care. As current prognostic tools may not generalize well across all CLD conditions, we aim to develop and validate a general model to predict one-year mortality in patients presenting with any CLD. A retrospective cohort study of patients with a CLD diagnosis at a public hospital from July 2016 to October 2017 was conducted. The outcome of interest was all-cause mortality within one-year of diagnosis. Potential prognostic factors were identified from reviews of prognostic studies in CLD, and data was extracted from electronic medical records. Missing data was imputed using multiple imputation by chained equations. Logistic regression models were developed using variable selection methods and validated in patients seen from January 2018 to December 2019. Discriminative ability, calibration and clinical usefulness of the model was assessed. Model coefficients and performance were pooled across all imputed datasets and reported. Of the 1000 patients, 122 (12.2%) died within one year. Patients had chronic obstructive pulmonary disease or emphysema (55%), bronchiectasis (38%), interstitial lung diseases (12%), or multiple diagnoses (6%). The model selected through forward stepwise variable selection had the highest AUC (0.77 (0.72-0.82)) and consisted of ten prognostic factors. The model AUC for the validation cohort was 0.75 (0.70, 0.81), and the calibration intercept and slope were - 0.14 (-0.54, 0.26) and 0.74 (0.53, 0.95) respectively. Classifying patients with a predicted risk of death exceeding 0.30 as high risk, the model would correctly identify 3 out 10 decedents and 9 of 10 survivors. We developed and validated a prognostic model for one-year mortality in patients with CLD using routinely available administrative data. The model will support clinicians in identifying patients across various CLD etiologies who are at risk of deterioration for a basic palliative care assessment to identify unmet needs and trigger an early referral to palliative medicine. Not applicable (retrospective study).
Sections du résumé
BACKGROUND
BACKGROUND
Patients with chronic lung diseases (CLDs), defined as progressive and life-limiting respiratory conditions, experience a heavy symptom burden as the conditions become more advanced, but palliative referral rates are low and late. Prognostic tools can help clinicians identify CLD patients at high risk of deterioration for needs assessments and referral to palliative care. As current prognostic tools may not generalize well across all CLD conditions, we aim to develop and validate a general model to predict one-year mortality in patients presenting with any CLD.
METHODS
METHODS
A retrospective cohort study of patients with a CLD diagnosis at a public hospital from July 2016 to October 2017 was conducted. The outcome of interest was all-cause mortality within one-year of diagnosis. Potential prognostic factors were identified from reviews of prognostic studies in CLD, and data was extracted from electronic medical records. Missing data was imputed using multiple imputation by chained equations. Logistic regression models were developed using variable selection methods and validated in patients seen from January 2018 to December 2019. Discriminative ability, calibration and clinical usefulness of the model was assessed. Model coefficients and performance were pooled across all imputed datasets and reported.
RESULTS
RESULTS
Of the 1000 patients, 122 (12.2%) died within one year. Patients had chronic obstructive pulmonary disease or emphysema (55%), bronchiectasis (38%), interstitial lung diseases (12%), or multiple diagnoses (6%). The model selected through forward stepwise variable selection had the highest AUC (0.77 (0.72-0.82)) and consisted of ten prognostic factors. The model AUC for the validation cohort was 0.75 (0.70, 0.81), and the calibration intercept and slope were - 0.14 (-0.54, 0.26) and 0.74 (0.53, 0.95) respectively. Classifying patients with a predicted risk of death exceeding 0.30 as high risk, the model would correctly identify 3 out 10 decedents and 9 of 10 survivors.
CONCLUSIONS
CONCLUSIONS
We developed and validated a prognostic model for one-year mortality in patients with CLD using routinely available administrative data. The model will support clinicians in identifying patients across various CLD etiologies who are at risk of deterioration for a basic palliative care assessment to identify unmet needs and trigger an early referral to palliative medicine.
TRIAL REGISTRATION
BACKGROUND
Not applicable (retrospective study).
Identifiants
pubmed: 39215286
doi: 10.1186/s12890-024-03233-0
pii: 10.1186/s12890-024-03233-0
pmc: PMC11365240
doi:
Types de publication
Journal Article
Validation Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
429Subventions
Organisme : National Medical Research Council
ID : HSRGEoL18may-0003
Informations de copyright
© 2024. The Author(s).
Références
Respiration. 2019;98(5):383-390
pubmed: 31578022
Medicine (Baltimore). 2022 Dec 30;101(52):e32537
pubmed: 36596005
Biom J. 2019 Mar;61(2):343-356
pubmed: 30353591
NPJ Prim Care Respir Med. 2022 Jan 13;32(1):2
pubmed: 35027570
Front Med (Lausanne). 2023 Oct 02;10:1220370
pubmed: 37849489
Age Ageing. 2022 Jan 6;51(1):
pubmed: 34673931
Biom J. 2018 May;60(3):431-449
pubmed: 29292533
Lancet Respir Med. 2020 Jun;8(6):585-596
pubmed: 32526187
J Res Nurs. 2019 Sep;24(6):420-430
pubmed: 34394556
Clin Med (Lond). 2014 Feb;14(1):79-82
pubmed: 24532753
JAMA Netw Open. 2019 Sep 4;2(9):e1911146
pubmed: 31517959
Palliat Med. 2020 Sep;34(8):1030-1043
pubmed: 32484762
Palliat Med. 2020 Sep;34(8):989-1005
pubmed: 32507025
Chest. 2015 Feb;147(2):423-429
pubmed: 25187973
Respir Res. 2011 Nov 14;12:151
pubmed: 22082049
Int J Chron Obstruct Pulmon Dis. 2017 May 11;12:1401-1411
pubmed: 28546748
Chest. 2015 Feb;147(2):430-437
pubmed: 25211374
Eur Respir J. 2022 Sep 15;60(3):
pubmed: 35728976
Chest. 2014 Apr;145(4):723-728
pubmed: 24114524
J Palliat Med. 2024 Mar;27(3):411-420
pubmed: 37702606
Int J Mol Sci. 2021 Aug 27;22(17):
pubmed: 34502194
Eur Heart J. 2014 Aug 1;35(29):1925-31
pubmed: 24898551
BMJ Support Palliat Care. 2021 Oct 18;:
pubmed: 34663595
Clin Respir J. 2023 Sep;17(9):831-840
pubmed: 36437511
Am J Respir Crit Care Med. 2022 Aug 15;206(4):e7-e41
pubmed: 35969190
Lung India. 2018 Jul-Aug;35(4):290-294
pubmed: 29970766
Ann Am Thorac Soc. 2016 Mar;13(3):311-6
pubmed: 26730490
Am J Respir Crit Care Med. 2023 Apr 1;207(7):819-837
pubmed: 36856433
Eur Clin Respir J. 2018 Oct 16;5(1):1530029
pubmed: 30357015
Ann Intern Med. 2012 May 15;156(10):684-91
pubmed: 22586007
Chest. 2022 May;161(5):1134-1135
pubmed: 35526883
Respir Med. 2021 Apr-May;180:106370
pubmed: 33765620
Eur Respir J. 2018 Feb 14;51(2):
pubmed: 29444916
BMC Med. 2019 Dec 16;17(1):230
pubmed: 31842878
Lancet. 2021 Sep 18;398(10305):1091-1104
pubmed: 34481560
J Palliat Med. 2019 May;22(5):538-544
pubmed: 30615545
Eur Respir J. 2018 May 24;51(5):
pubmed: 29794123
Diagn Progn Res. 2021 Jan 11;5(1):1
pubmed: 33431065
Ann Am Thorac Soc. 2013 Apr;10(2):81-9
pubmed: 23607835
Arch Intern Med. 2006 Feb 13;166(3):326-31
pubmed: 16476873
Eur Respir J. 2021 Jan 28;57(1):
pubmed: 32859672
Medicina (Kaunas). 2021 May 11;57(5):
pubmed: 34064756
J Thorac Dis. 2020 May;12(5):2791-2802
pubmed: 32642187
BMC Med. 2023 Feb 24;21(1):70
pubmed: 36829188
Chest. 2015 Nov;148(5):1268-1275
pubmed: 25996795
Respir Med. 2021 Nov-Dec;189:106659
pubmed: 34700206
Biom J. 2023 Dec;65(8):e2200302
pubmed: 37466257
BMJ. 2019 Oct 4;367:l5358
pubmed: 31585960
Int J Chron Obstruct Pulmon Dis. 2017 Jul 31;12:2239-2256
pubmed: 28814852
Eur Respir J. 2023 Aug 17;62(2):
pubmed: 37290789
BMC Pulm Med. 2022 Apr 4;22(1):125
pubmed: 35379214
Biosci Rep. 2020 Oct 30;40(10):
pubmed: 33057706
J Clin Epidemiol. 1996 Dec;49(12):1373-9
pubmed: 8970487